
IndraLab
Statements
reach
"The essential role of USP7 during cell cycle progression and apoptosis has been reported by other groups: i) USP7 knockdown leads to increased p53 expression and arrest of cell cycle (Cummins et al., 2004), ii) USP7 regulated various tumor-related factors expression (p53, Ki-67) in bladder cancer and prostate cancer (Song et al., 2008; Morra et al., 2019)."
reach
"USP7 disrupts the equilibrium of the p53-dependent MDM2 axis, leading to the proteasomal degradation of p53 and ultimately decreasing the expression of PD-L1 on the surface of tumor cells.120, 121, 122 Several USP7 inhibitors are currently in preclinical trials and further studies are required."
reach
"Although several Daxx interacting proteins are involved in critical cellular pathways regarding P53 degradation, such as ubiquitin-specific-processing protease 7 (USP7) and mouse double minute 2 (Mdm2) [XREF_BIBR, XREF_BIBR], it is still unclear whether Daxx has any role in tumorigenicity of OSCC."
reach
"Notably, TSPYL5 interacts with USP7 (ubiquitin specific peptidase 7) to reduce the tumor suppressor activity of p53, overriding p53-dependent proliferation arrest [12], promoting endothelial cell proliferation and angiogenesis [15], and protecting POT1 (protection of telomeres 1) from proteasomal degradation in ALT (alternative lengthening of telomeres)-positive cells [16]."
reach
"These findings suggested that USP7 downregulated by I3MO triggers p53 and p65 degradation and suppresses its downstream signaling transduction.Our previous study indicated that USP7/NEK2/NF-κB pathway activation plays pivotal roles in bortezomib resistance in MM.7 39 Since the stabilization of NEK2 by USP7 is required for the release of p65 into the nucleus, we further investigate whether downregulation of USP7 involved in I3MO efficacy via triggering NEK2 degradation and suppresses its downstream signaling transduction."
reach
"This indicates that MDM2 inhibitor activity in the RKO cell line is on target and related to the induction of p53, and that the more modest induction of p53 elicited by USP7 inhibition is insufficient to inhibit proliferation in this cell line.These findings highlight significant mechanistic differences between the effects of MDM2 inhibitors and USP7 inhibitors in healthy and neoplastic cells."
eidos
"The essential role of USP7 during cell cycle progression and apoptosis has been reported by other groups : i ) USP7 knockdown leads to increased p53 expression and arrest of cell cycle ( Cummins et al ., 2004 ) , ii ) USP7 regulated various tumor-related factors expression ( p53 , Ki-67 ) in bladder cancer and prostate cancer ( Song et al ., 2008 ; Morra et al ., 2019 ) ."